BCA
ABMD

Berman Capital Advisors’s Abiomed Inc ABMD Stock Holding History

Berman Capital Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$47K Buy
147
+89
+153% +$30.1K 0.01% 709
2021
Q2 		$18K Buy
58
+7
+14% +$2.15K ﹤0.01% 959
2021
Q1 		$16K Buy
51
+14
+38% +$4.48K ﹤0.01% 880
2020
Q4 		$11K Buy
37
+21
+131% +$5.81K ﹤0.01% 910
2020
Q3 		$4K Hold
16
– – ﹤0.01% 1152
2020
Q2 		$3K Buy
16
+4
+33% +$803 ﹤0.01% 1202
2020
Q1 		$1K Buy
12
+4
+50% +$664 ﹤0.01% 1415
2019
Q4 		$1K Sell
8
-27
-77% -$5.01K ﹤0.01% 1422
2019
Q3 		$6K Sell
35
-14
-29% -$3.03K ﹤0.01% 918
2019
Q2 		$12K Buy
49
+23
+88% +$6.1K ﹤0.01% 676
2019
Q1 		$7K Buy
26
+5
+24% +$1.66K ﹤0.01% 795
2018
Q4 		$6K Buy
+21
New +$7.29K ﹤0.01% 656

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Berman Capital Advisors's ABMD Position: Q3 2021 in Review

Berman Capital Advisors increased its Abiomed Inc (ABMD) stake by 153% in Q3 2021, buying an estimated $30.1K and bringing the position to 147 shares worth $47K. The position accounts for 0.01% of the portfolio, ranked #709.

Berman Capital Advisors first reported a position in ABMD in Q4 2018 and has held it in 12 quarters since. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2021.

  • Berman Capital Advisors held 147 shares of Abiomed Inc worth $47K as of Q3 2021.
  • Berman Capital Advisors bought 89 Abiomed Inc shares in Q3 2021, an estimated $30.1K.
  • Abiomed Inc made up 0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #709 holding.
  • Berman Capital Advisors first reported a position in Abiomed Inc in Q4 2018 and has held it in 12 quarters since.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.